HALO logo
halo search icon
Addex Therapeutics Ltd Sponsored ADR

US$6.78

Price Change Indicator
-0.22 (-3.143%)
Addex Therapeutics Ltd Sponsored ADR
ADXN · NAS

Addex Therapeutics Ltd Sponsored ADR

Start Trading ADXN for Free

US$6.78

Price Arrow-0.22 (-3.143%)
20/05/2026 02:24:50 PM
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Addex Therapeutics Ltd Sponsored ADR Overview

ADXN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ADXN

icon
icon

Telephone

41.22.884.15.55

icon

Address

Plan-les-Ouates, 9, Chemin des Mines, Geneva, Geneve (Geneva) 1202

Description

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

ADXN Price Chart

Key Stats

Market Cap

US$12.84M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.41 - 12.05

Trade Value (12mth)

US$26,952.00

1 week

2.79%

1 month

-0.43%

YTD

-13.47%

1 year

-14.74%

All time high

750.40

Key Fundamentals

EPS 3 yr Growth

-84.30%

EBITDA Margin

NaN%

Operating Cashflow

-$3m

Free Cash Flow Return

-31.20%

ROIC

-98.40%

Interest Coverage

NaN

Quick Ratio

1.40

Other Data

Shares Outstanding (Fully Diluted)

1m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ADXN Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
16 May 26
30 April 26
29 April 26

ADXN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-18.979.8-9.05locklocklock
EPS (Fully Diluted)
 $locklocklocklock-18.975.73-9.05locklocklock
Growth
 %locklocklocklock67.2151.7-192.4locklocklock
PE
 XlocklocklocklockN/A0.7N/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS)?
Halo FAQ
The current share price of Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) is USD$6.78.
What is the 52-week high share price for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS)?
Halo FAQ
The 52-week high share price for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) is USD$12.05.
What is the 52-week low share price for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS)?
Halo FAQ
The 52-week low share price for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) is USD$5.41.
What is the dividend yield for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS)?
Halo FAQ
Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) does not pay a dividend.
What was Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) last dividend payment?
Halo FAQ
Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) does not pay a dividend.
What is the franking level for Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS)?
Halo FAQ
Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) has a franking level of 0.00%.
In which sector is Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) classified?
Halo FAQ
Addex Therapeutics Ltd Sponsored ADR (ADXN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial